We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2024 Shift.ms

@MrVelocity 

Last reply

MrVelocity

What is Multiple Sclerosis!

Before you explain anything watch this video: http://youtu.be/SX7kHhmrelI Afterwards you may comment... I will respond to your comment as we discuss this topic. I look forward to your response because this got me thinking about things. In particular B cells!
8
@US-Emma
@US-Emma
 

Rituximab is being used in the states for PPMS, it targets B cells and re dosing is dependent on the patients CD19 %, if it climbs above 1% they redoee the patient (based on monthly blood work). This turns out to be approx every 4-6 months. This is also an add on option to Lemtrada to prevent the autoimmune side effects of thyroid disorder, ITP & Goodpastures. I personally have not decided to proceed with Ritux or not, my 6 month mark (when we would decide) comes up in October.

@Stumbler
@Stumbler
 

Here's a short discussion on the topic :- http://multiple-sclerosis-research.blogspot.co.uk/2014/09/depleting-b-cells-in-cns.html